In an April 17 post titled “Why it’s time to scrutinize global medical supply chain security,” an AMA news writer said the COVID-19 pandemic highlighted longstanding vulnerabilities in the global supply chain. Policymakers, healthcare organizations, regulators, manufacturers and distributors are responsible for these issues, according to the article.
“Ongoing failures to cultivate public health capacity, nourish sustainable production processes and carefully maintain systemic supply chain resiliency are unjust,” the post said.
In AMA Journal of Ethics, recent articles urge the World Health Organization to distinguish between drugs that are “essential” and those “vulnerable” to shortages; what policymakers and prescribers should know about imported medicines; ethical guidelines for providing care during resource constraints; and how critical medicines should be rationed during a shortage.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.